Sabine Lauer
TU Dortmund University(DE)Wilhelmina Children's Hospital(NL)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Breast Cancer Treatment Studies, Diabetes Treatment and Management, Statistical Methods in Clinical Trials
Most-Cited Works
- → 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial(2017)1,014 cited
- → Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy(2017)162 cited
- → A Plea for Neutral Comparison Studies in Computational Sciences(2013)145 cited
- → Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients(2017)46 cited
- → A Statistical Framework for Hypothesis Testing in Real Data Comparison Studies(2015)38 cited
- → Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial